β2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses

Science. 2018 Mar 2;359(6379):1056-1061. doi: 10.1126/science.aan4829.

Abstract

The type 2 inflammatory response is induced by various environmental and infectious stimuli. Although recent studies identified group 2 innate lymphoid cells (ILC2s) as potent sources of type 2 cytokines, the molecular pathways controlling ILC2 responses are incompletely defined. Here we demonstrate that murine ILC2s express the β2-adrenergic receptor (β2AR) and colocalize with adrenergic neurons in the intestine. β2AR deficiency resulted in exaggerated ILC2 responses and type 2 inflammation in intestinal and lung tissues. Conversely, β2AR agonist treatment was associated with impaired ILC2 responses and reduced inflammation in vivo. Mechanistically, we demonstrate that the β2AR pathway is a cell-intrinsic negative regulator of ILC2 responses through inhibition of cell proliferation and effector function. Collectively, these data provide the first evidence of a neuronal-derived regulatory circuit that limits ILC2-dependent type 2 inflammation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity*
  • Adrenergic Neurons / immunology*
  • Adrenergic beta-2 Receptor Agonists / pharmacology
  • Animals
  • Humans
  • Immunity, Innate*
  • Inflammation / immunology
  • Intestines / immunology
  • Lung / immunology
  • Lymphocytes / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Nerve Net / immunology
  • Receptors, Adrenergic, beta-2 / genetics
  • Receptors, Adrenergic, beta-2 / metabolism*
  • Signal Transduction

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Receptors, Adrenergic, beta-2